Jane Chung insider trades

Open-market stock purchases and sales by Jane Chung, Chief Executive Officer at Sutro Biopharma, Inc, from SEC Form 4 filings since Aug 9, 2021.

Recent trades

DateStockTradeValue
Mar 4, 2026STRO Sutro Biopharma, IncSold (not open market)$6K
Mar 4, 2026STRO Sutro Biopharma, IncBought (not open market)—
Mar 2, 2026STRO Sutro Biopharma, IncBought (not open market)—
Mar 2, 2026STRO Sutro Biopharma, IncBought (not open market)—
Mar 2, 2026STRO Sutro Biopharma, IncSold (not open market)$57.1K
Mar 2, 2026STRO Sutro Biopharma, IncBought (not open market)—
Mar 1, 2026STRO Sutro Biopharma, IncBought (not open market)—
Mar 1, 2026STRO Sutro Biopharma, IncSold (not open market)$26K
Mar 1, 2026STRO Sutro Biopharma, IncBought (not open market)—
Dec 12, 2025STRO Sutro Biopharma, IncSold (not open market)$7.2K
Dec 12, 2025STRO Sutro Biopharma, IncBought (not open market)—
Oct 15, 2025STRO Sutro Biopharma, IncBought$10K

Companies traded

  • STRO Sutro Biopharma, Inc: 1 buy, last Mar 4, 2026
  • VIRX Viracta Therapeutics, Inc: other filings, last Jun 20, 2024

Get free alerts when Jane Chung files a new trade →